FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Meeting on Drugs for Preventing Preterm Birth

Federal Register notice: FDA announces a 1/23/24/2024 public meeting entitled Advancing Drug Development for the Prevention of Spontaneous Preterm Bir...

latest-news-card-1
Federal Register

Final Rule on DTC Ad Major Statement

Federal Register final rule: FDA posts a final rule on direct-to-consumer advertisements and a requirement that the major statement must be presented ...

latest-news-card-1
Medical Devices

GLP Report Translation Q&A Guidance

FDA publishes a draft guidance with questions and answers on translating GLP study reports into English.

Human Drugs

Concerns Over FDA Biosimilar Labeling Draft Guide

Four stakeholders differ on an FDA draft guidance suggesting a new approach to biosimilar labeling on interchangeability.

latest-news-card-1
Human Drugs

Repeat CGMP Violations at Cipla Plant

FDA warns Cipla about CGMP and other violations at its Madhya Pradesh, India-based drug manufacturing facility.

latest-news-card-1
Medical Devices

SoClean Recalls CPAP Device Cleaners

SoClean recalls its SoClean2 and SoClean3 equipment that is used to clean, sanitize, or disinfect CPAP sleep apnea devices and accessories.

latest-news-card-1

Study New Guide on Science Info for MDs: Attorneys

Three Epstein Becker Green attorneys analyze a new FDA draft guidance on communicating scientific information on unapproved uses of medical products.

latest-news-card-1
Medical Devices

Medtronics Symplicity for Hypertension Approved

FDA approves a Medtronic PMA for its Symplicity Spyral renal denervation system for treating hypertension.

latest-news-card-1
Human Drugs

Abecma Review Delayed for Panel Input

FDA delays a 12/16-expected review decision on a Bristol Myers Squibb and 2seventy bio supplemental BLA for Abecma (idecabtagene vicleucel) and its us...

latest-news-card-1
Federal Register

Meeting on Rare Disease Patient Engagement

Federal Register notice: FDA announces a 12/14 public meeting entitled Advancing the Development of Therapeutics Through Rare Disease Patient Communit...